USD/JPY Trades Above Key Level as Investors Await BoJ Intervention: Asia-Pacific Outlook


Japanese Yen, USD/JPY, Bank of Japan, Sentiment, Technical Outlook – Talking Points

  • Asia-Pacific stocks face headwinds from higher Treasury yields to close the week
  • Japanese inflation data in focus as heavy volume of options trades set to expire
  • USD/JPY above 150 puts traders on alert for possible BoJ market intervention

Friday’s Asia-Pacific Outlook

Asia-Pacific stocks are looking at a mixed open as higher yields in the US weigh on global sentiment. The Wall Street trading session didn’t offer much hope for traders. The benchmark S&P 500 fell 0.8% on Thursday. Treasury yields rose across the curve, but more so along the longer end, which eased the 10-year/2-year yield gap inversion to around -38 basis points. While peak hawkishness appears to be the current view in overnight index swaps and Fed funds futures, hawkish comments from several FOMC members spooked equity investors.

The British Pound gained after news of Liz Truss’s plans to resign crossed the wires, but early strength was trimmed, and GBP/USD traded nearly unchanged shortly after the NY closing bell. A new successor may be named as soon as Monday, with front runners seen in Boris Johnson—yes…the former PM who was recently ousted—and Rishi Sunak, among others. Ms. Truss’s resignation likely puts an end to Gilt market turmoil.

This morning, South Korea’s producer price index (PPI) for September crossed the wires at 0.2% from the month before, up from -0.4% in August, indicating rising factory-gate prices. New Zealand’s trade balance is due this morning. The weak Kiwi Dollar has added costs to imports, and a deficit may continue over the short term. The island nation posted a 2.4 billion deficit in August. A growing deficit would likely weigh on NZD.

Japan’s September consumer price index (CPI) is expected to cross the wires at 3.0% from the year before. That would be up from 2.8% in August. Like with NZ, a weak Yen adds inflationary pressures, complicating the Bank of Japan’s monetary efforts. The Yen is on track to weaken against the Dollar for the twelfth day, an impressive feat. With USD/JPY above 150, we can likely expect aggressive jawboning from Japanese policymakers.

Japanese Yen Technical Outlook

USD/JPY is now above the 150 level but just barely. The BoJ may choose to intervene around these levels, but technically, prices look due for a short-term pullback. That could mean a brief drop to the rising 9-day Exponential Moving Average (EMA), which has supported prices going back to August. The Relative Strength Index reached its highest levels since early 2022, reflecting the aggressive JPY selling over the past 12 days.

USD/JPY Daily Chart

Chart created with TradingView

— Written by Thomas Westwater, Analyst for DailyFX.com

To contact Thomas, use the comments section below or @FxWestwater on Twitter





Source link

Related articles

Depreciation Subtleties: S&P Earnings Are Vastly Overstated (NYSEARCA:SPY)

Depreciation expense schedules do catch up over time, as this expense merchandise will likely be recurring for the subsequent 5.5 to six years, however due to how quickly capex has...

The Feds May Do One thing About These Distractingly Shiny Headlights

The blinding glare of LED headlights from oncoming site visitors searing your retinas might grow to be a factor of the previous. The Nationwide Freeway Visitors Security Administration introduced this week that it...

NY AG Secures As much as $35M in Celsius Founder Alex Mashinsky Settlement

Former Celsius CEO Alex Mashinsky has been completely barred from the cryptocurrency, securities and commodities industries below a settlement with New York Legal professional Common Letitia James that features as much as $35...

Ledger Probes Reseller Provide Chain as Analysts Monitor $86 Million in Suspected Drains

XTB Provides In a single day US Inventory Buying and selling; Nasdaq Ventures Invests in One Buying and selling ...

Polyphron Raises $20M to Predict Drug Toxicity in Human Tissue Earlier than Medical Trials – AlleyWatch

AI can now generate extra drug candidates than scientists can check. The arduous half is proving which of them work in people, as a result of animal research and scientific trials transfer slowly...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com